4//SEC Filing
Smith Michael Eric 4
Accession 0001213900-22-002896
CIK 0001779020other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 8:28 PM ET
Size
9.7 KB
Accession
0001213900-22-002896
Insider Transaction Report
Form 4
Smith Michael Eric
Chief Operating Officer
Transactions
- Sale
Common Stock
2022-01-18$6.20/sh−10,000$61,960→ 348,744 total - Exercise/Conversion
Class A Common Stock ("Common Stock")
2022-01-18$3.28/sh+10,000$32,800→ 358,744 total - Exercise/Conversion
Stock Option (right to purchase)
2022-01-18−10,000→ 618,909 totalExercise: $3.28Exp: 2026-06-30→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]Includes 348,744 restricted shares of the Common Stock granted under a previously disclosed restricted stock award.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Smith on June 25, 2021. The Reporting Person exercised no discretion with respect to the sale. Proceeds from the sale were used to pay the exercise price of stock options, pursuant to a broker-assisted cashless exercise, and applicable withholding taxes.
- [F3]The January 18, 2022 sale of 10,000 shares of Common Stock was executed in multiple trades at prices ranging from $6.185 to $6.225. The price reported above reflects the volume-weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The options are fully vested and currently exercisable.
Documents
Issuer
Danimer Scientific, Inc.
CIK 0001779020
Entity typeother
Related Parties
1- filerCIK 0001836650
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 8:28 PM ET
- Size
- 9.7 KB